| Application no. and date | 17739696.7 (espacenet) (Federated) (European Patent Register), 20170612 | | Patent/reg. no. and date | DK/EP 3468957, 20200826 | | Publication date | 20190417 | | Priority no. and date | WO PCT/CN2016/085694, 20160614 | | EP pub. no. and date |
EP 3468957 20190417 | | Effective date | | | Applicant/owner | NOVARTIS AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | V49767DK00 | | Inventor | FU, Jiping, Novartis Institutes for BioMedical Research Inc.
5300 Chiron Way
Emeryville, California 94608, US,
JIANG, Siyi, Beijing Novartis Pharma Co. Ltd.
4218 Jinke Road
Zhangjiang Hi-Tech Park
Shanghai 201203, CN,
KORDIKOWSKI, Andreas, Novartis Pharma AG
Postfach
CH-4002 Basel, CH,
SWEENEY, Zachary Kevin, 143 King Street
Redwood City, California 94602, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/42 (2006.01) , A61P 31/04 (2006.01) , C07D 261/08 (2006.01) | | Title | KRYSTALLINSK FORM AF (R)-4-(5-(CYCLOPRO
PYLETHYNYL)ISOXAZOL-3-YL)-N-HYDROXY-2-METHYL-2-(METHYLSULFONYL)BUTANAMID SOM ET ANTIBAKTERIELT MIDDEL | | Int. application no. | IB2017053468 | | Int. publication no. | WO2017216705 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
